Loading…
Oaktree Acquisition Corp. III Life Sciences is projected to rise to $14.40 by 2027, a +34% move from its current price of $10.74. OACC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $10.72 | $10.75 | $10.78 | +0.10% |
| Aug 4 | $10.72 | $10.76 | $10.80 | +0.19% |
| Aug 5 | $10.72 | $10.77 | $10.82 | +0.29% |
| Aug 6 | $10.73 | $10.78 | $10.84 | +0.39% |
| Aug 7 | $10.73 | $10.79 | $10.86 | +0.48% |
| Aug 8 | $10.73 | $10.80 | $10.87 | +0.58% |
| Aug 9 | $10.74 | $10.81 | $10.89 | +0.68% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.74 | $10.81 | $10.89 | +0.68% |
| Week 2 | $10.78 | $10.89 | $10.99 | +1.36% |
| Week 3 | $10.83 | $10.96 | $11.09 | +2.05% |
| Week 4 | $10.88 | $11.03 | $11.19 | +2.75% |
| Week 5 | $10.94 | $11.11 | $11.28 | +3.44% |
| Week 6 | $11.00 | $11.19 | $11.38 | +4.15% |
| Week 7 | $11.06 | $11.26 | $11.47 | +4.85% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe.
The company was founded in 1995 and is headquartered in Los Angeles, California.
Oaktree Acquisition Corp. III Life Sciences (OACC) is currently priced at $10.71, reflecting its trading level and market activity.
Its market cap stands at $263.28M and it is ranked 3520 in market listings.
The price outlook, based on the year-by-year forecast, shows a path of rising averages through 2030, 2040, and 2050 with average prices of $18.55, $49.43, and $87.90 respectively and ROIs of 73.2, 361.6, and 720.8.
A major floor 1.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.8% away) — a key level to hold.
Price is pressing into resistance (0.1% away) — a breakout level to watch.
A major ceiling 0.7% above — clearing it would confirm fresh momentum.
Key OACC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OACC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.73 | Buy | $10.73 | Buy |
| MA 10 | $10.72 | Buy | $10.72 | Buy |
| MA 20 | $10.71 | Buy | $10.71 | Buy |
| MA 50 | $10.69 | Buy | $10.69 | Buy |
| MA 100 | $10.67 | Buy | $10.67 | Buy |
| MA 200 | $10.64 | Buy | $10.62 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.30 | Neutral |
| Stoch RSI (14) | 44.30 | Neutral |
| CCI (20) | 160.49 | Buy |
| Williams %R (14) | -20.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 0.37 | Buy |
| Bollinger %B (20,2) | 0.96 | Neutral |
| Stochastic %K (14) | 80.00 | Neutral |
| TRIX (15) | 0.02 | Buy |
| Awesome (5,34) | 0.04 | Buy |
| Ultimate (7,14,28) | 68.09 | Neutral |
| Momentum (10) | 0.04 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 10.74 | Sell |
| ADX (14) | 19.15 | Neutral |
| ATR (14) | 0.01 | Info |
The near-term technical picture is bullish.
RSI14 is 60, with the 50-day simple moving average at $10.68 and the 200-day simple moving average at $10.64. Support is at $10.65 and resistance at $10.74. The 30-day price range runs from $10.62 to $10.80. Annualized volatility is 3.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.56 | $10.74 | $14.55 | 0% | Neutral | |
| $11.80 | $14.40 | $18.34 | +34% | Bullish | |
| $12.73 | $15.82 | $20.72 | +47% | Bullish | |
| $14.42 | $18.20 | $24.34 | +69% | Bullish | |
| $14.65 | $18.75 | $25.53 | +75% | Bullish | |
| $15.02 | $19.46 | $26.92 | +81% | Bullish | |
| $17.44 | $22.84 | $32.05 | +113% | Bullish | |
| $20.40 | $26.99 | $38.37 | +151% | Bullish | |
| $22.72 | $30.37 | $43.69 | +183% | Bullish | |
| $23.67 | $31.94 | $46.46 | +197% | Bullish | |
| $35.15 | $49.48 | $75.44 | +361% | Bullish | |
| $58.52 | $88.34 | $144.40 | +723% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $10.56 | $10.74 | $13.15 | +0.00% |
| September 2026 | $9.90 | $11.61 | $13.91 | +8.07% |
| October 2026 | $9.96 | $11.73 | $14.17 | +1.06% |
| November 2026 | $9.85 | $11.65 | $14.15 | -0.72% |
| December 2026 | $10.04 | $11.91 | $14.55 | +2.25% |
Click any year to see its month-by-month OACC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, OACC is projected to trade between $10.56 and $14.55, averaging $10.74 — a potential gain of 0% from today's $10.74. A consolidation phase looks the most probable path here.
Oaktree Acquisition Corp. III Life Sciences's 2027 outlook centres on $14.40, within a $11.80 to $18.34 range. That is up +34% on the projected 2026 average. That marks a +34% change versus current levels. Momentum favours further upside here.
By 2028, OACC could reach as high as $20.72, with a base case around $15.82 and support toward $12.73 — roughly +47% from $10.74. Buyers look set to stay in control over this stretch.
Expect OACC to range from $14.42 to $24.34 through 2029. The $18.20 average target implies a +69% move from current prices. That is up +15% on the projected 2028 average. Momentum favours further upside here.
The OACC price prediction for 2030 points to an average of $18.75 (low $14.65, high $25.53) — a potential gain of +75% on today's $10.74. Buyers look set to stay in control over this stretch.
In 2031, OACC is projected to trade between $15.02 and $26.92, averaging $19.46 — a potential gain of +81% from today's $10.74. That is up +4% on the projected 2030 average. Momentum favours further upside here.
Oaktree Acquisition Corp. III Life Sciences's 2032 outlook centres on $22.84, within a $17.44 to $32.05 range. That is up +17% on the projected 2031 average. That marks a +113% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, OACC could reach as high as $38.37, with a base case around $26.99 and support toward $20.40 — roughly +151% from $10.74. Momentum favours further upside here.
Expect OACC to range from $22.72 to $43.69 through 2034. The $30.37 average target implies a +183% move from current prices. That is up +13% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The OACC price prediction for 2035 points to an average of $31.94 (low $23.67, high $46.46) — a potential gain of +197% on today's $10.74. Momentum favours further upside here.
In 2040, OACC is projected to trade between $35.15 and $75.44, averaging $49.48 — a potential gain of +361% from today's $10.74. That is up +55% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Oaktree Acquisition Corp. III Life Sciences's 2050 outlook centres on $88.34, within a $58.52 to $144.40 range. That is up +79% on the projected 2040 average. That marks a +723% change versus current levels. Momentum favours further upside here.
Investing $1,000 in OACC today (≈ 93.10987 OACC) could be worth
$8,225.48
+$7,225.48 (+723%) by 2050 · US Dollar
Based on the average projected OACC price of $88.34 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OACCwould be worth at today's price.
$1,000 invested in OACC on Jul 31, 2025 (≈ 95.510981 OACC) would be worth
$1,025.79
+$25.79 (+2.6%) today · 1.03× · US Dollar
Based on a OACC entry price of $10.47 vs. today's $10.74.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.71 | $1,002.8 | +0.3% |
| 1 month ago | $10.7 | $1,003.74 | +0.4% |
| 3 months ago | $10.6 | $1,013.21 | +1.3% |
| 6 months ago | $10.69 | $1,004.68 | +0.5% |
| 1 year ago | $10.47 | $1,025.79 | +2.6% |
| All time (1.6y) ago | $10 | $1,074 | +7.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OACC forecast.
Our base-case forecast reaches $21.00 around 2032.
Implied market cap at $21.00: $415.44M
The multi-year forecast shows a bullish trajectory, with rising averages and positive sentiment through the forecast horizon.
2030: avg $18.55, min $14.50, max $25.28, ROI 73.2, sentiment BULLISH.
2040: avg $49.43, min $35.11, max $75.38, ROI 361.6, sentiment BULLISH.
2050: avg $87.90, min $58.22, max $143.70, ROI 720.8, sentiment BULLISH.
The outlook from 2027 onward is bullish in the provided forecast, with continuing gains in average price and ROI while acknowledging inherent uncertainty in long-horizon projections.
Tap a question to reveal the answer.
Avg price $18.55, min $14.50, max $25.28; ROI 73.2; sentiment BULLISH.
Forecasts show bullish sentiment in 2027 (avg $14.35, ROI 34) and 2028 (avg $15.80, ROI 47.5) with rising averages through 2029 (avg $18.27, ROI 70.6) and beyond (2030 avg $18.55, ROI 73.2; 2031+ bullish). Some early-year neutrality is noted for 2026 (avg $10.71, ROI 0, sentiment NEUTRAL).
Yes, the max forecast by 2050 is $143.70 with ROI 720.8% (2040 max $75.38; 2030 max $25.28).
Current price is $10.71 and market cap is $263.28M.
Sentiment: BULLISH. RSI14: 60. SMA50: $10.68. SMA200: $10.64. Support: $10.65. Resistance: $10.74. 30-day range: $10.62-$10.80. Annualized volatility: 3.
Oaktree Acquisition Corp. III Life Sciences Community Discussion
0Share your Oaktree Acquisition Corp. III Life Sciences price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.